Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
description Rank Gene Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 501 to 550 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
carboxypeptidase b precursor. [source:refseq;acc:nm\_020361]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
509\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
177.698\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
190.239\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07057\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
carboxypeptidase h precursor (ec 3.4.17.10) (cph) (carboxypeptidase e) (cpe) (enkephalin convertase) (prohormone processing carboxypeptidase). [source:swissprot;acc:p16870]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
717\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
223.121\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
211.685\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05402\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
carboxypeptidase n catalytic chain precursor (ec 3.4.17.3) (arginine carboxypeptidase) (kininase 1) (serum carboxypeptidase n) (scpn) (anaphylatoxin inactivator) (plasma carboxypeptidase b). [source:swissprot;acc:p15169]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
715\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
carcinoma related gene. [source:refseq;acc:nm\_016041]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3179\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
carnitine o-acetyltransferase (ec 2.3.1.7) (carnitine acetylase) (cat). [source:swissprot;acc:p43155]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1698\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.624\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01367\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
carnitine o-palmitoyltransferase ii, mitochondrial precursor (ec 2.3.1.21) (cpt ii). [source:swissprot;acc:p23786]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2885\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cartilage oligomeric matrix protein precursor (comp). [source:swissprot;acc:p49747]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
226\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
239.991\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
269.238\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12187\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase i alpha s-like. [source:refseq;acc:nm\_145203]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1495\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
229.459\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
225.237\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01874\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase i, alpha isoform (ec 2.7.1.-) (cki-alpha) (ck1). [source:swissprot;acc:p48729]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1496\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase i, delta isoform (ec 2.7.1.-) (cki-delta) (ckid). [source:swissprot;acc:p48730]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1721\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
227.125\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.164\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01321\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase i, epsilon isoform (ec 2.7.1.-) (cki-epsilon) (ckie). [source:swissprot;acc:p49674]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1710\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
227.225\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01345\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase i, gamma 1 isoform (ec 2.7.1.-) (cki-gamma 1). [source:swissprot;acc:q9hcp0]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2830\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase i, gamma 2 isoform (ec 2.7.1.-) (cki-gamma 2). [source:swissprot;acc:p78368]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2986\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase i, gamma 3 isoform (ec 2.7.1.-) (cki-gamma 3). [source:swissprot;acc:q9y6m4]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2901\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase ii beta chain (ck ii) (phosvitin) (g5a). [source:swissprot;acc:p13862]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
936\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
232.473\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.372\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03611\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase ii, alpha chain (ck ii) (ec 2.7.1.37). [source:swissprot;acc:p19138]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
863\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
240.194\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
230.957\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03999\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase ii, alpha' chain (ck ii) (ec 2.7.1.37). [source:swissprot;acc:p19784]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
864\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
caspase-7 precursor (ec 3.4.22.-) (ice-like apoptotic protease 3) (ice-lap3) (apoptotic protease mch-3) (cmh-1). [source:swissprot;acc:p55210]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1292\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
233.942\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.024\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
catenin (cadherin-associated protein), alpha-like 1; alpha-catulin. [source:refseq;acc:nm\_003798]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1834\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
180.409\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
182.459\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01136\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cathepsin b precursor (ec 3.4.22.1) (cathepsin b1) (app secretase). [source:swissprot;acc:p07858]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1667\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
214.898\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.898\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01416\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cathepsin l precursor (ec 3.4.22.15) (major excreted protein) (mep). [source:swissprot;acc:p07711]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1426\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
214.717\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.157\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02068\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
cathepsin l2 precursor (ec 3.4.22.43) (cathepsin v) (cathepsin u). [source:swissprot;acc:o60911]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1425\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
caveolin-1. [source:swissprot;acc:q03135]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3099\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
caveolin-3 (m-caveolin). [source:swissprot;acc:p56539]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2779\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cbf1 interacting corepressor. [source:refseq;acc:nm\_004882]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
572\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
227.86\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.945\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06504\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cbl e3 ubiquitin protein ligase (ec 6.3.2.-) (signal transduction protein cbl) (proto-oncogene c-cbl). [source:swissprot;acc:p22681]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
762\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
213.256\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.237\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0493\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ccaat displacement protein (cdp) (cut-like 1). [source:swissprot;acc:p39880]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
556\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
207.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
194.368\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06638\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ccaat-binding transcription factor subunit b (cbf-b) (nf-y protein chain a) (nf-ya) (caat-box dna binding protein subunit a). [source:swissprot;acc:p23511]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
36\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
260.532\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.309\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.27519\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ccaat-box-binding transcription factor (ccaat-binding factor) (cbf). [source:swissprot;acc:q03701]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
408\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
255.112\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
234.804\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08649\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ccr4-not transcription complex, subunit 3; not3 (negative regulator of transcription 3, yeast) homolog. [source:refseq;acc:nm\_014516]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3163\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ccr4-not transcription complex, subunit 4; not4 (negative regulator of transcription 4, yeast) homolog; ccr4-not transcription complex, subunit. [source:refseq;acc:nm\_013316]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1390\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.47\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.875\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02148\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ccr4-not transcription complex, subunit 6-like. [source:refseq;acc:nm\_144571]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2958\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
ccr4-not transcription complex, subunit 7 (ccr4-associated factor 1) (caf1) (btg1 binding factor 1). [source:swissprot;acc:q9uiv1]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3226\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
ccr4-not transcription complex, subunit 8 (caf1-like protein) (califp). [source:swissprot;acc:q9uff9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2890\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cd109; gov system alloantigens on platelets. [source:refseq;acc:nm\_133493]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2075\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.703\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.483\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00803\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cd209 antigen-like; putative type ii membrane protein. [source:refseq;acc:nm\_014257]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
418\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
233.539\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
253.197\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08417\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
cd209 antigen; dendritic cell-specific icam3-grabbing nonintegrin. [source:refseq;acc:nm\_021155]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
420\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cda11 protein. [source:refseq;acc:nm\_032026]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1579\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
213.181\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
209.732\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01644\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cdc42 guanine exchange factor 9; hpem-2 collybistin. [source:refseq;acc:nm\_015185]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1778\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.878\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.286\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0121\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cdc42-interacting protein 4 (thyroid receptor interacting protein 10) (trip-10). [source:swissprot;acc:q15642]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
437\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
209.921\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.459\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07878\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cdc5-like; cdc5 (cell division cycle 5, s. pombe, homolog)-like; cell division cycle 5, s. pombe, homolog-like; cdc5-related protein. [source:refseq;acc:nm\_001253]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
692\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.602\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.195\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05532\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cdk-activating kinase assembly factor mat1 (ring finger protein mat1) (menage a trois) (cdk7/cyclin h assembly factor) (p36) (p35) (cyclin g1 interacting protein). [source:swissprot;acc:p51948]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3209\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cdp-diacylglycerol--inositol 3-phosphatidyltransferase (ec 2.7.8.11) (phosphatidylinositol synthase) (ptdins synthase) (pi synthase). [source:swissprot;acc:o14735]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2155\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
200.063\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
198.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00681\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cell adhesion molecule with homology to l1cam precursor; neural cell adhesion molecule; cell adhesion molecule l1-like; l1 cell adhesion molecule 2. [source:refseq;acc:nm\_006614]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2739\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
198.278\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
198.321\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00022\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cell division control protein 2 homolog (ec 2.7.1.-) (p34 protein kinase) (cyclin-dependent kinase 1) (cdk1). [source:swissprot;acc:p06493]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1585\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
168.145\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
170.888\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01631\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cell division cycle protein 23; anaphase-promoting complex subunit 8. [source:refseq;acc:nm\_004661]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1481\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
208.432\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.516\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01915\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cell division protein kinase 2 (ec 2.7.1.-) (p33 protein kinase). [source:swissprot;acc:p24941]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1583\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
168.091\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
170.837\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01634\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cell division protein kinase 3 (ec 2.7.1.-). [source:swissprot;acc:q00526]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1581\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
168.002\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
170.753\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01637\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cell division protein kinase 5 (ec 2.7.1.-) (tau protein kinase ii catalytic subunit) (tpkii catalytic subunit) (serine/threonine protein kinase pssalre). [source:swissprot;acc:q00535]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2850\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
cell division protein kinase 8 (ec 2.7.1.-) (protein kinase k35). [source:swissprot;acc:p49336]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2990\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/